Plasma p-tau212 as a biomarker of sporadic and Down Syndrome Alzheimer's disease.

Autor: Kac PR; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden., Alcolea D; Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain., Montoliu-Gaya L; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden., Fernández S; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain., Rodriguez JL; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden., Maure L; Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain., González-Ortiz F; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden., Benejam B; Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain., Turton M; Bioventix Plc, Farnham, GU9 7SX, United Kingdom., Barroeta I; Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain., Harrison P; Bioventix Plc, Farnham, GU9 7SX, United Kingdom., Videla L; Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain., Ashton NJ; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.; NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, United Kingdom.; Department of Old Age Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, London, United Kingdom., Lleó A; Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain., Zetterberg H; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.; UK Dementia Research Institute at UCL, London, United Kingdom., Carmona-Iragui M; Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain., Karikari TK; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Fortea J; Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.; Barcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain., Blennow K; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.; Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, P.R. China.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Nov 02. Date of Electronic Publication: 2024 Nov 02.

21595. EFECTOS DE LA ENFERMEDAD DE ALZHEIMER EN EL SUEÑO DE ADULTOS CON SÍNDROME DE DOWN

Autor: Giménez Badia, S., Arranz, J., Benejam, B., Videla, L., Carmona, M., Vázquez, L., Arriola, J., Rodríguez, I., Barroeta, I., Bejanin, A., Fernández, A., Rozalem, M., Morcillo, A., Maure, L., Fernández, S., Lleó, A., Fortea, J.

Publikováno v: In Neurology Perspectives November 2024 4 Supplement 1:138-138

Publicity, Privacy and Secrecy

Autor: Goldschmidt, Maure L.

Publikováno v: The Western Political Quarterly, 1954 Sep 01. 7(3), 401-416.

Externí odkaz: https://www.jstor.org/stable/442761

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rousseau on Intermediate Associations

Autor: Maure L. Goldschmidt

Publikováno v: Voluntary Associations ISBN: 9781351299800
Voluntary Associations

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fe2c5f96a35ad6f6d4ca1168cab8359b
https://doi.org/10.4324/9781351299800-8